Abstract
West Nile virus appeared in the Americas for the first time in 1999 and spread rapidly in the following years. Although an acute infection, it was found to be transfusion-transmissible in 2002, and donor testing for WNV RNA was initiated throughout the United States by the summer of 2003. Testing in minipools was not adequately sensitive, and mechanisms were developed for rapid implementation of individual donation testing in times and areas of high incidence of human infection. Overall, the response has been very effective and may offer lessons for managing future outbreaks of acute, transfusion-transmissible infections.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Campbell GL, Marfin AA, Lanciotti RS, Gubler DJ. West Nile virus. Lancet Infect Dis. 2002;2:519–29.
Petersen LR, Brault AC, Nasci RS. West Nile virus: review of the literature. JAMA. 2013;310:308–15.
Centers for Disease Control. Outbreak of West Nile-like viral encephalitis – New York, 1999. MMWR. 1999;48:845–9.
Petersen LR, Hayes EB. Westward Ho? The spread of West Nile virus. N Engl J Med. 2004;351:2257–9.
Petersen LR, Fischer M. Unpredictable and difficult to control – the adolescence of West Nile virus. N Engl J Med. 2012;367:1281–4.
Biggerstaff BJ, Petersen LR. Estimated risk of West Nile virus transmission through blood transfusion in Queens, New York City. Transfusion. 2002;42:1019–26.
Pealer LN, Marfin AA, Petersen LR, Lanciotti RS, Page PL, Stramer SL, et al. Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med. 2003;349:1236–45.
Stramer SL, Fang CT, Foster GA, Wagner AG, Brodsky JP, Dodd RY. West Nile virus among blood donors in the United States, 2003 and 2004. N Engl J Med. 2005;353:451–9.
Busch MP, Caglioti S, Robertson EF, McCauley JD, Tobler LH, Kamel H, et al. Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing. N Engl J Med. 2005;353:460–7.
Dodd RY, Foster GA, Stramer SL. Keeping blood safe from West Nile virus: American Red Cross Experience, 2003–2012. Transfus Med Rev. 2015;29:153–61.
Meny GM, Santos-Zabala L, Szallasi A, Stramer SL. West Nile virus infection transmitted by granulocyte transfusion. Blood. 2011;117:5778–9.
Orton SL, Stramer SL, Dodd RY. Self-reported symptoms associated with West Nile virus infection in RNA-positive blood donors. Transfusion. 2006;46:272–7.
Dodd RY. Emerging infections, transfusion safety, and epidemiology. N Engl J Med. 2003;349:1205–6.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Dodd, R.Y. (2019). Case Study: West Nile Virus. In: Shan, H., Dodd, R. (eds) Blood Safety . Springer, Cham. https://doi.org/10.1007/978-3-319-94436-4_8
Download citation
DOI: https://doi.org/10.1007/978-3-319-94436-4_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-94435-7
Online ISBN: 978-3-319-94436-4
eBook Packages: MedicineMedicine (R0)